Used primarily as a key intermediate in pharmaceutical synthesis, especially in the development of kinase inhibitors for cancer treatment. Its boronic ester group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds in complex molecules. Commonly employed in research and development of targeted therapies, including those for oncology and inflammatory diseases. Also utilized in the preparation of radiolabeled compounds for imaging studies and drug metabolism evaluation.